Serological diagnosis of dengue by an ELISA inhibition method (EIM).
about
Infectious Chikungunya Virus in the Saliva of Mice, Monkeys and HumansNeutralizing antibodies after infection with dengue 1 virusAntibody avidity following secondary dengue virus type 2 infection across a range of disease severityAdvances in dengue diagnosisPhenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue feverDiagnosis of Dengue Virus Infection by the Visual and Simple AuBioDOT Immunoglobulin M Capture SystemReemergence of Dengue in Cuba: A 1998 Epidemic in Santiago de CubaHigh dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance dataUnusual dengue virus 3 epidemic in Nicaragua, 2009Evaluation of the diagnostic utility of the traditional and revised WHO dengue case definitionsEvaluation of the traditional and revised WHO classifications of Dengue disease severityIndex cluster study of dengue virus infection in Nicaragua.Early clinical features of dengue virus infection in nicaraguan children: a longitudinal analysis.Temporal dynamics of the transcriptional response to dengue virus infection in Nicaraguan childrenTherapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected].Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans.Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and salivaSymptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year.Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases.The Nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004-2010.Antibodies against immature virions are not a discriminating factor for dengue disease severity.Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Severe Dengue OutcomeDominant cross-reactive B cell response during secondary acute dengue virus infection in humansDengue 3 epidemic, Havana, 2001.Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunityImmunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype.Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity.Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets.Serological evidence of flaviviruses and alphaviruses in livestock and wildlife in Trinidad.Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua.The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases.Antibody-based assay discriminates Zika virus infection from other flaviviruses.Homotypic Dengue Virus Reinfections in Nicaraguan Children.High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua.Characterization of Dengue Virus Infections Among Febrile Children Clinically Diagnosed With a Non-Dengue Illness, Managua, Nicaragua.Development of in-house serological methods for diagnosis and surveillance of chikungunya.Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.Seroepidemiology of selected alphaviruses and flaviviruses in bats in Trinidad.Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes.Distinguishing secondary dengue virus infection from Zika virus infection with previous dengue by a combination of three simple serological tests.
P2860
Q24288650-3DF4E321-4B41-4C60-96FA-E7F92C67FC4FQ24652746-5FCB8C21-19B1-4889-9DBA-059408C77D3CQ26700094-432476B8-C452-45CF-A075-C6EDBEE8B4EAQ27477784-42AEC0BD-3432-4A0A-A0A0-686DBCF491F2Q27486912-C5CF840B-138E-4F55-9E14-315C9FE105CEQ27487562-41CFD0B8-353D-4A4C-9A53-F00637D9689DQ27487594-2503907E-95F7-43C9-B619-B5D303E9628DQ28473212-A1666844-F0C3-4D5B-ADF6-31201086CDDAQ30409538-2C418DFB-51F8-44C0-AC25-4EDFABC8E159Q31134161-8C27D05C-3134-4FE4-8915-48C88265119CQ34075766-ABDF1BB5-EBF8-44B9-99ED-83CFEB7CFC4EQ34087481-DCB66E5D-8E95-4E21-96A6-AC0AEBA84742Q34193896-261D4A1A-5472-4622-8E1F-333F112DF652Q34535311-5ABFFBE6-7225-4505-BF4C-8E76C2D864A8Q34607919-4A5F28AD-FCAA-4B8A-A307-6C54723E620EQ34779065-3BA18ABE-1679-4212-938F-57F3EB20C822Q34779136-3EF7FD4D-286C-4C57-ADE4-011A61492CB2Q34952330-CDA0AEAE-6BC8-44EE-86EF-859109E68D2DQ34999885-43D4D72A-2D0E-4A76-AF3C-633FF14B954DQ35006549-15D5CD43-79E3-4062-84B8-F95767C3873FQ35168403-94916B1E-0916-4E16-9307-E7A910E8051EQ35763159-8D93EA36-1CEE-4E28-A03B-62058F437AA1Q35842365-1C580719-30D8-449C-8FE8-2E08FEE5AEA5Q35880240-F346920F-20E6-432A-9B3B-B58DA7CD2491Q35895444-44DAD873-6863-4B5A-8212-DA8D1C93F677Q35935142-8D748D83-8278-418E-8F18-8A59FDA413C5Q36172100-49C5733E-3FC3-4D0D-9F0F-DBE73452FE7AQ36250195-EA9CBBD4-0FDC-4C0C-A53D-8531E06E64B0Q36378910-D7DBA75C-1A75-4E64-803A-621C664A5663Q37047163-16428115-909B-4A35-A17B-F5A5B7FC49A0Q37238713-D9DB97C0-7114-4357-BCE0-9DEAFF8C5171Q38157718-7BC5F9F9-688C-48C0-814A-84D3D13A75CFQ38381598-A78C9440-6927-4C96-ABA5-FC8AD6909622Q39758756-CC87EF86-A655-4B20-88F9-3ABE0240856BQ40040985-40131178-3A2F-4A49-9528-D84021CA7E8BQ40043816-CE572900-CDB5-4536-932D-282947EDA62AQ40062304-4F74F31C-ED57-4C0C-B646-BA2F5B09A646Q40185972-21BDB0DF-4078-4AEE-A242-013D0A2C82CEQ41676281-8E33E45C-B864-4C64-BBA4-8AE2AC0D5CDFQ41918088-3B44F313-07D2-4292-9CDD-265430FE6527
P2860
Serological diagnosis of dengue by an ELISA inhibition method (EIM).
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Serological diagnosis of dengue by an ELISA inhibition method (EIM).
@en
Serological diagnosis of dengue by an ELISA inhibition method
@nl
type
label
Serological diagnosis of dengue by an ELISA inhibition method (EIM).
@en
Serological diagnosis of dengue by an ELISA inhibition method
@nl
prefLabel
Serological diagnosis of dengue by an ELISA inhibition method (EIM).
@en
Serological diagnosis of dengue by an ELISA inhibition method
@nl
P1476
Serological diagnosis of dengue by an ELISA inhibition method (EIM).
@en
P2093
Fernández RJ
P304
P356
10.1590/S0074-02761990000300012
P577
1990-07-01T00:00:00Z